A heated menstrual cup includes a main cup body comprising an upper section defining a substantially circular opening and a lower section comprising a fluid collection portion defining a closed lower end; and a flexible ring configured for removable attachment to the upper section of the flexible main cup body at the open upper end and further configured to be positioned around a cervix of a female human, the flexible ring defining a channel entirely enclosed therein. The flexible ring includes a sealed air container positioned within the channel, the air container containing air and comprising a frangible shell constructed to be broken to unseal the air container and release the air into the channel; and a thermogenic composition contained within the channel in isolation from air when the sealed air container is sealed, the thermogenic composition comprising one or more components that generate heat when in contact with the air released from the air container.

Disclosed are a medical fiberous structure and a method for preparing the same, wherein the medical fiberous structure comprises calcium carboxymethyl cellulose and a chitosan compound, at least one of the calcium carboxymethyl cellulose and the chitosan compound having a fibrous shape.

Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

Novel compositions and systems for closure of wounds are disclosed. The compositions provide devices of improved flexibility and elasticity and are readily applied to wound sites or over wound closure devices. The present invention is also directed to a novel platinum catalyst for use in such compositions. The catalyst provides for rapid curing on topical surfaces such as skin and bonds to such surfaces in about 2-5 minutes.

The present disclosure provides functional fibrous material comprising fibers associated with hydrogel containing micro-flakes. The present disclosure also provides a method of forming hydrogel micro-flakes having embedded therein at least one microorganism and a method of preparing functional fibrous material, both methods comprise a step of subjecting a mixture of hydrogel and microbial material to high shear forces to form micro-flakes comprising the hydrogel with at least one microorganism embedded therein. Further provided is a method of treatment of a target comprising contacting the target with the disclosed functional fibrous material as well as the micro-flakes disclosed herein.

A system for treating open wounds includes a foam material configured for pouring, spraying, injecting or spreading on a wound bed. The foam material can comprise a base component and a curing component, which can be pre-mixed before application, or mixed in situ as the components are being applied to the wound site. A third component can comprise a sacrificial porogen. Foam can be placed in the wound bed as a wound liner on the wound surfaces. An additional foam insulation can provide a foam filler partially contained by the wound liner and generally flush with a patient's epidermis. A method of treating open wounds includes the steps of applying the wound liner and filler components. An optional step comprises covering the wound liner with a semi-permeable (breathable) membrane and mounting inlet and outlet ports thereon for introducing healing compositions as input, and extracting wound exudates as output.

Disclosed are nasal dressings and nasal stents comprising a collagen foam. Also disclosed are methods of making and using such nasal dressings and nasal stents. In an embodiment, a nasal dressing or nasal stent is formed by a method comprising the steps of: forming an aqueous mixture of from 5 to 25 wt % of acid-soluble collagen and from 75 to 95 wt % of collagen fibers, both based on the total solids content of the aqueous mixture, placing the aqueous mixture into a mold, freeze-drying the aqueous mixture while in the mold, thereby forming a collagen foam, and cross-linking the collagen foam.

An anti-curling film is provided. The anti-curling film includes a first portion and a second portion covering the first portion. The first portion includes polylactic acid (PLA), polycaprolactone (PCL), polyethylene glycol dimethacrylate (PEGDMA) and a photoinitiator. The second portion includes polycaprolactone (PCL), gelatin, hyaluronic acid (HA), alginate (AA), polyvinyl alcohol (PVA) or a combination thereof.

A polymeric material that includes a thermoplastic composition containing a continuous phase that includes a matrix polymer and a siloxane component is provided. The siloxane component contains an ultrahigh molecular weight siloxane polymer that is dispersed within the continuous phase in the form of discrete domains. A porous network is defined within the thermoplastic composition that includes a plurality of nanopores.

Disclosed embodiments relate to wound care materials and methods that comprise a self-gelling composition, configured to form a gel upon contacting fluid. The self-gelling composition is a substantially homogeneous mixture, and comprises fluid-absorbent particles loaded with iodine-based antimicrobial agent, a dehydrated hydrogel powder, and a polymer base, configured to allow dispensing the self-gelling composition from a syringe or tube and to prevent the self-gelling composition from gelling prior to contacting fluid. The gel performs one or more of the following tasks during a wear time, when applied at the wound: absorbing fluid or exudate, releasing iodine-based antimicrobial agent, achieving antimicrobial activities at the wound, remaining structurally integral and cohesive, protecting the wound from exposure to microorganisms, and facilitating healing. After a wear time of at least three days, the gel can be removed in two pieces or less and leave less than 5% residue by weight.